Prestige Consumer Healthcare (PBH) EBT Margin (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly EBT Margin of 21.81% in Q4 2025, down 13.53% quarter-over-quarter from 25.22% in Q3 2025, and down 580.0% on a YoY basis from 4.54% in Q4 2024.
Prestige Consumer Healthcare (PBH) EBT Margin (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's EBT Margin history runs 16 years deep, the most recent figure standing at 21.81% for Q4 2025.
- In Q4 2025, EBT Margin fell 580.0% year-over-year to 21.81%; the TTM figure through Dec 2025 stood at 24.16% (down 66.0% YoY), while the FY2025 annual figure was 24.98%, up 45.0% from the prior year.
- EBT Margin was 21.81% for Q4 2025 at Prestige Consumer Healthcare, down from 25.22% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 28.37% in Q2 2021 to a low of 104.78% in Q1 2023.
- Historically, EBT Margin has averaged 17.59% across 5 years, with a median of 24.6% in 2023.
- The sharpest annual moves came in 2023 and 2024: EBT Margin slumped 12761 bps in 2023, then jumped 12908 bps in 2024.
- A 5-year view of EBT Margin shows it stood at 23.86% in 2021, then increased by 4 bps to 24.72% in 2022, then fell by 0 bps to 24.61% in 2023, then climbed by 12 bps to 27.61% in 2024, then fell by 21 bps to 21.81% in 2025.
- The last three EBT Margin figures came in at 21.81% (Q4 2025), 25.22% (Q3 2025), and 24.76% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 10.97% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 33.51% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 40.73% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 25.87% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 30.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.35% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -156.77% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -16.70% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 41.45% |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | 21.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.81% |
| Sep 30, 2025 | 25.22% |
| Jun 30, 2025 | 24.76% |
| Mar 31, 2025 | 24.94% |
| Dec 31, 2024 | 27.61% |
| Sep 30, 2024 | 25.25% |
| Jun 30, 2024 | 21.87% |
| Mar 31, 2024 | 24.30% |
| Dec 31, 2023 | 24.61% |
| Sep 30, 2023 | 24.59% |
| Jun 30, 2023 | 24.60% |
| Mar 31, 2023 | -104.78% |
| Dec 31, 2022 | 24.72% |
| Sep 30, 2022 | 23.02% |
| Jun 30, 2022 | 25.59% |
| Mar 31, 2022 | 22.84% |
| Dec 31, 2021 | 23.86% |
| Sep 30, 2021 | 21.59% |
| Jun 30, 2021 | 28.37% |
| Mar 31, 2021 | 16.98% |